Tandem Diabetes Care (NASDAQ: TNDM) is a medical device company that designs, manufactures, and sells insulin delivery systems for people with diabetes. The filing excerpts provided do not contain sufficient detail to support specific revenue figures, segment breakdowns, product names, customer counts, geographic mix, competitor names, founding year, or leadership details. Based solely on the available filing excerpts, a fully sourced canonical description cannot be constructed to the required specificity standards. The excerpts confirm only that Tandem Diabetes Care filed a 10-K with the SEC for the fiscal year ended in the period covered by the filing dated 2026-02-19 under accession number 000143813326000010, and that the company is listed on a national exchange under the ticker TNDM. All additional business detail would require support from filing body text not present in the provided excerpts.

Source: SEC 10-K, filed 2026-02-19

Industry: Surgical & Medical Instruments & Apparatus Peers: Abbott Laboratories Axonics, Inc. Enovis Corp Conmed Corp Glaukos Corp Inari Medical, Inc. Integra Lifesciences Holdings Corp iRhythm Holdings, Inc NUVASIVE INC Omnicell Inc